Results 131 to 140 of about 20,292 (247)

A Remote Chronic Disease Management Program to Improve Cardiovascular and Metabolic Outcomes in a Diverse Community‐Based Diabetic Population: Study Design of the TAMIS Trial

Journal of Evaluation in Clinical Practice, Volume 32, Issue 4, June 2026.
ABSTRACT Introduction Cardiovascular and cerebrovascular diseases are projected to expand in the coming decades as the main cause of death. This study outlines the escalating burden of cardiovascular diseases in low‐ and middle‐income countries (LMICs), particularly in Latin America (LA), which is expected to surpass that of other high‐population ...
Renato de Carvalho Barros, Andrea Stephanus, José Antonio Barbosa Filho, Evellyn Mariana, Yasmim Botelho, Thaiene M. M. Severino, Robson Conceição Silva, Lucila de Jesus Almeida, Cristiane Koeche, Bruno Gedeon, Mariana Guimarães Souza de Oliveira, Ana Carolina Augusto, Catarina Ferraz, F. Enzo, Gabriela de Lima, Julia Andrade Ibiapina, Giselle Pinto, Sérgio Henrique Rodolpho Ramalho, Ana Claudia C. Nogueira, Andrei C. Sposito, Alessandra M. Campos‐Staffico, Alexandre Anderson S. M. Soares, Luiz Sérgio F. de Carvalho   +22 more
wiley   +1 more source

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia

Frontiers in Cardiovascular Medicine
AimsHistorically, atherosclerotic cardiovascular disease (ASCVD) risk profile mitigation has had a predominant focus on low density lipoprotein cholesterol (LDL-C).
Bilal Bashir, Bilal Bashir, Bilal Bashir, Jonathan Schofield, Paul Downie, Michael France, Darren M. Ashcroft, Darren M. Ashcroft, Alison K. Wright, Alison K. Wright, Stefano Romeo, Stefano Romeo, Stefano Romeo, Ioanna Gouni-Berthold, Akhlaq Maan, Paul N. Durrington, Handrean Soran, Handrean Soran, Handrean Soran   +18 more
doaj   +1 more source

High cholesterol absorption efficiency enhances proatherogenic properties of low‐density lipoprotein particles

Journal of Internal Medicine, Volume 299, Issue 6, Page 711-725, June 2026.
Abstract Background and Aims High cholesterol absorption efficiency is determined by genetic variation in small intestinal sterol transporters and affects one‐third of individuals. Their risk for atherosclerotic cardiovascular disease (ASCVD) is increased compared with low cholesterol absorbers, despite similar serum lipid concentrations.
Katariina Öörni, Lauri Äikäs, Maija Ruuth, Feven Tigistu‐Sahle, Reijo Käkelä, Ingmar Wester, Helena Gylling, Piia Simonen   +7 more
wiley   +1 more source

Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis

American Journal of Preventive Cardiology
Objective: To determine the performance of the PREVENT equation for estimating atherosclerotic cardiovascular disease (ASCVD) risk in rheumatoid arthritis (RA) compared to the American College of Cardiology/American Heart Association ASCVD risk estimator,
Ilana M. Usiskin, Brittany N. Weber, Ying Qi, Katherine Zhong, Mary Jeffway, Michael E. Weinblatt, Nancy Shadick, Jorge Plutzky, Katherine P. Liao   +8 more
doaj   +1 more source

Osteocalcin value to identify subclinical atherosclerosis over atherosclerotic cardiovascular disease (ASCVD) risk score in middle-aged and elderly Chinese asymptomatic men

, 2018
Background:Our study examined whether osteocalcin contributed to identifying carotid intima-media thickness (C-IMT) over the atherosclerotic cardiovascular disease (ASCVD) risk score.Methods:We recruited 618 middle-aged and elderly men from communities ...
Xiaojing Ma, Yuqian Bao, Qin Xiong, Xueli Zhang, Yiting Xu, Yun Shen   +5 more
core   +1 more source

Fibrotic NASH Index (FNI) Is Associated with Long‐Term Mortality in Individuals with Type 2 Diabetes and MASLD

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aim Metabolic dysfunction‐associated steatotic liver disease (MASLD) frequently coexists with type 2 diabetes (T2D) and increases cardiovascular disease (CVD) risk, with hepatic fibrosis being the main determinant of mortality.
Ilaria Barchetta, Flavia Agata Cimini, Sara Dule, Giulia Passarella, Alessandro Oldani, Maria Neve Hirsch, Marta Cirelli, Marta Alfano, Maria Gisella Cavallo   +8 more
wiley   +1 more source

Association between serum carcinoembryonic antigen levels and atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus

European Journal of Medical Research
Background Atherosclerotic cardiovascular disease (ASCVD) is cardiovascular disease caused by atherosclerosis. Serum carcinoembryonic antigen (CEA), a common tumor marker, is positively associated with arterial stiffness in healthy adults. Therefore, the
You-Fan Peng, Xiang-Hui Su, Ying-Qi Lv, Lin Hu, Teng-Fang Lai, Li Wang, Guo-Feng Wang, Ling Li   +7 more
doaj   +1 more source

Enhancing Air Quality Index Activity Guidelines for Preventing Cardiovascular Events in the General Adult Population

JACC: Advances
Background: The public health relevance of daily Air Quality Index (AQI) activity guidelines for the general adult public in the United States to prevent atherosclerotic cardiovascular disease (ASCVD) events is questionable.
Robert D. Brook, MD, Allison R. Brook, BS, Phillip D. Levy, MD, MPH, Steven Korzeniewski, PhD, Sadeer Al-Kindi, MD, Sanjay Rajagopalan, MD   +5 more
doaj   +1 more source

LL‐37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults

Physiological Reports, Volume 14, Issue 12, June 2026.
Abstract Elevated LL‐37 IgG levels are implicated in inflammatory conditions and immune complexes formed with LL‐37 potentially propagate immunothrombosis in acute coronary syndrome (ACS). The reported binding of LL‐37 to LDL may be relevant in this context given that LDL autoantibodies are implicated in ACS risk. In this report, three distinct cohorts
Paul C. Dimayuga, Jianchang Zhou, Xiaoning Zhao, Kuang‐Yuh Chyu, Prediman K. Shah, Bojan Cercek   +5 more
wiley   +1 more source

Atherogenic Dyslipoproteinemia and Management of ASCVD

Journal of the American College of Cardiology, 2020
Gerald F. Watts, Dick C. Chan
openaire   +1 more source